Management of sepsis in the ICU

International Anesthesiology Clinics

Volumn 47, Issue 1, 2009, Pages 55-66

  Trejnowska, Ewa ^a   Popovich, Marc J ^b  

^a Province Medical Center   (Poland)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED PROTEIN C; ANTIBIOTIC AGENT; CORTICOSTEROID; DOPAMINE; DROTRECOGIN; HYPERTENSIVE AGENT; HYPERTENSIVE FACTOR; INOTROPIC AGENT; INSULIN; LACTIC ACID; NORADRENALIN; STEROID; VASOPRESSIN; ANTIDIABETIC AGENT; ANTIINFECTIVE AGENT; PROTEIN C; VASOCONSTRICTOR AGENT;

ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; CLINICAL TRIAL; DRUG CHOICE; DRUG EFFECT; HEART ARRHYTHMIA; HUMAN; HYPERGLYCEMIA; HYPERLACTATEMIA; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; LOW DRUG DOSE; PATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SEPSIS; SEPTIC SHOCK; SHOCK; TACHYCARDIA; INTENSIVE CARE; NOMENCLATURE;

ADRENAL CORTEX HORMONES; ANTI-INFECTIVE AGENTS; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INTENSIVE CARE; INTENSIVE CARE UNITS; LACTIC ACID; PROTEIN C; RESPIRATION, ARTIFICIAL; RESUSCITATION; SEPSIS; TERMINOLOGY AS TOPIC; VASOCONSTRICTOR AGENTS;

EID: 64549150179     PISSN: 00205907     EISSN: None     Source Type: Journal    
DOI: 10.1097/AIA.0b013e318194ffb6     Document Type: Review

References (32)

1. Wenzel RP. Treating sepsis. New Engl J Med. 2002;347:966-967.
2. Dellinger RP, Levy MM, Carlet JM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008 [published correction appears in Crit Care Med 2008;36:1394-1396]. Crit Care Med. 2008;36:296-327.
3. Eichacker PQ, Natanson C, Danner RL. Surviving sepsis - practice guidelines, marketing campaigns, and Eli Lilly. New Engl J Med. 2006;355:1640-1642. (Pubitemid 44583953)
4. Russell JA. Management of sepsis. New Engl J Med. 2006;355:1699-1713.
5. Raghavan M, Marik PE. Management of sepsis during the early "golden hours." J Emer Med. 2006;31:185-199.
6. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. New Engl J Med. 2001;345:1368-1377. (Pubitemid 34940725)
7. Otero RM, Nguyen B, Huang DT, et al. Early goal-directed therapy in severe sepsis and septic shock revisited: Concepts, controversies, and contemporary findings. Chest. 2006;130:1579-1595. (Pubitemid 44786757)
8. Marik PE, Varon J. Goal-directed therapy for severe sepsis. New Engl J Med. 2002;346:1025. Correspondence.
9. Abroug F, Besbes L, Nouira S. Goal-directed therapy for severe sepsis. New Engl J Med. 2002;346:1025. Correspondence.
10. Waters JH, Gottlieb A, Schoenwald P, et al. Normal saline versus lactated Ringer's solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair. Anesth Analg. 2001;93:817-822. (Pubitemid 32905961)
11. The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. New Engl J Med. 2004;350:2247-2256.
12. Ernest D, Belzberg AS, Dodek P. Distribution of normal saline and 5% albumin infusions in septic patients. Crit Care Med. 1999;27:46-50. (Pubitemid 29052813)
13. Revelly JP, Tappy L, Martinez A, et al. Lactate and glucose metabolism in severe sepsis and septic shock. Crit Care Med. 2005;33:2235-2240. (Pubitemid 41437476)
14. Bellomo R, Chapman M, Finfer S, et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomized trial. Lancet. 2000;356: 2139-2143. (Pubitemid 32047951)
15. Kellum JA, Decker M. Use of dopamine in acute renal failure: a meta-analysis. Crit Care Med. 2001;29:1526-1531. (Pubitemid 32762331)
16. Marik PE. Low-dose dopamine: a systematic review. Intensive Care Med. 2002;28: 877-883.
17. Albanese J, Leone M, Garnier F, et al. Renal effects of norepinephrine in septic and nonseptic patients. Chest. 2004;126:534-539. (Pubitemid 39093440)
18. Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med. 2001;345:588-595.
19. Russell JA, Walley KR, Singer J, et al. Vasopressin plus norepinephrine infusion in patients with septic shock. New Engl J Med. 2008;358:877-887.
20. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000;342:1301-1308.
21. The National Heart, Lung and Blood Institute ARDS Clinical Trials Network. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. New Engl J Med. 2004;351:327-336.
22. The ARDS Clinical Trials Network; National Heart, Lung, and Blood Institute; National Institutes of Health. Effects of recruitment maneuvers in patients with acute lung injury and acute respiratory distress syndrome ventilated with high positive end-expiratory pressure. Crit Care Med. 2003;31:2592-2597.
23. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension prior to initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589-1596. (Pubitemid 43810035)
24. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699-709. (Pubitemid 32204987)
25. Abraham E, Laterre PF, Garg R, et al. Drotrecogin alpha (activated) for adults with severe sepsis and a low risk of death. N Engl J Med. 2005;353:1332-1341. (Pubitemid 41362701)
26. Annane D, Sébille V, Troché G, et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotrophin. JAMA. 2000;283: 1038-1045. (Pubitemid 30112218)
27. Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA. 2002;288:862-871. (Pubitemid 34898534)
28. Marik PE, Zaloga GP. Adrenal insufficiency during septic shock. Crit Care Med. 2003;31:141-145.
29. Sprung CL, Annane D, Keh D, et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med. 2008;358:111-124.
30. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001;345:1359-1367. (Pubitemid 34940724)
31. Wilmer A, van den Berghe G. Management of sepsis. N Engl J Med. 2007;356:178. Correspondence.
32. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354:449-461. (Pubitemid 43200296)